share_log

6-K: Novo Nordisk A/S Purchases B Shares Worth Dkk 5,428 Million from Novo Holdings A/S Under the 2024 Share Repurchase Programme

6-K: Novo Nordisk A/S Purchases B Shares Worth Dkk 5,428 Million from Novo Holdings A/S Under the 2024 Share Repurchase Programme

諾和諾德| 6-K：根據2024年股票回購計劃，諾和諾德從Novo Holdings A/S購買價值54.28億丹麥克朗的B股
美股sec公告 ·  05/07 05:15
牛牛AI助理已提取核心訊息
On May 6, 2024, Novo Nordisk A/S, a leading global healthcare company, announced the purchase of 6,311,250 B shares from Novo Holdings A/S, valued at DKK 5.43 billion. This transaction is a part of Novo Nordisk's 2024 share repurchase program, which is set to reach up to DKK 20 billion over a 12-month period starting February 6, 2024. The shares were bought at a price of DKK 860.02 each, based on the volume weighted average market price from May 2 to May 6, 2024. Prior to this transaction, Novo Holdings A/S held 28.3% of Novo Nordisk's share capital and 77.4% of the votes. Post-transaction, their stake slightly decreased to 28.2% of the capital and 77.3% of the votes. The share repurchase aligns with Novo Holdings A/S's intention to...Show More
On May 6, 2024, Novo Nordisk A/S, a leading global healthcare company, announced the purchase of 6,311,250 B shares from Novo Holdings A/S, valued at DKK 5.43 billion. This transaction is a part of Novo Nordisk's 2024 share repurchase program, which is set to reach up to DKK 20 billion over a 12-month period starting February 6, 2024. The shares were bought at a price of DKK 860.02 each, based on the volume weighted average market price from May 2 to May 6, 2024. Prior to this transaction, Novo Holdings A/S held 28.3% of Novo Nordisk's share capital and 77.4% of the votes. Post-transaction, their stake slightly decreased to 28.2% of the capital and 77.3% of the votes. The share repurchase aligns with Novo Holdings A/S's intention to maintain its ownership at approximately 28% of Novo Nordisk's share capital, as announced on January 31, 2024. Additionally, incentive programs at Novo Nordisk resulted in a net transfer of 93,461 B shares between May 2 and May 6, 2024. Following these transactions, Novo Nordisk holds 10,163,508 B shares as treasury shares, representing 0.2% of the share capital. The total number of A and B shares in the company, including treasury shares, is 4,465,000,000.
2024年5月6日，全球領先的醫療保健公司諾和諾德A/S宣佈從Novo Holdings A/S購買6,311,2500億股股票，價值54.3億丹麥克朗。該交易是諾和諾德2024年股票回購計劃的一部分，該計劃將在2024年2月6日開始的12個月內達到高達200億丹麥克朗。根據2024年5月2日至5月6日的成交量加權平均市場價格，這些股票以每股860.02丹麥克朗的價格收購。在本次交易之前，Novo Holdings A/S持有諾和諾德28.3％的股本和77.4％的選票。交易後，他們的股份略有下降至資本的28.2％和選票的77.3％。股票回購符合諾和控股公司於2024年1月31日宣佈的將其所有權...展開全部
2024年5月6日，全球領先的醫療保健公司諾和諾德A/S宣佈從Novo Holdings A/S購買6,311,2500億股股票，價值54.3億丹麥克朗。該交易是諾和諾德2024年股票回購計劃的一部分，該計劃將在2024年2月6日開始的12個月內達到高達200億丹麥克朗。根據2024年5月2日至5月6日的成交量加權平均市場價格，這些股票以每股860.02丹麥克朗的價格收購。在本次交易之前，Novo Holdings A/S持有諾和諾德28.3％的股本和77.4％的選票。交易後，他們的股份略有下降至資本的28.2％和選票的77.3％。股票回購符合諾和控股公司於2024年1月31日宣佈的將其所有權維持在諾和諾德股本約28％的意圖。此外，諾和諾德的激勵計劃導致2024年5月2日至5月6日期間淨轉讓了93,461億股股票。在這些交易之後，諾和諾德持有10,163,508億股股票作爲庫存股，佔股本的0.2％。該公司的A股和B股總數，包括庫存股，爲44.65億股。

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。